KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Recent Clinical Development & Regulatory Highlights: Reported Positive Data from Phase 1 Proof-of-Concept Clinical Trial of KP415 Received Clearance from …